PODD · Healthcare
Insulet Corp
29/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
39
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$9.8B
Industry
Medical Devices
Sector
Healthcare
Exchange
NasdaqGS
About INSULET CORP
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager…
Who's behind the signal
Every informed buyer we can see on PODD, across all three feeds.
Hedge funds · 7
AQR Capital Management
Increased +248%
Millennium Management (Englander)
Increased +28%
D.E. Shaw & Co
Increased +377%
Citadel Advisors
Increased +58%
Baillie Gifford & Co
Unchanged
Bridgewater Associates (Dalio)
Decreased −38%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 6 on record
Disclosures from 2018-03-02 to 2021-02-16
The newest disclosure we hold for this stock is 2021-02-16.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-02-16 | Peter Meijer · R-MI | House | Sold | $15,001 - $50,000 |
| 2020-03-17 | Tina Smith · D-MN | Senate | Sold | $250,001 - $500,000 |
| 2018-08-30 | Tina Smith · D-MN | Senate | Sold | $15,001 - $50,000 |
| 2018-08-30 | Tina Smith · D-MN | Senate | Sold | $250,001 - $500,000 |
| 2018-06-01 | Tina Smith · D-MN | Senate | Sold | $100,001 - $250,000 |
| 2018-03-02 | Tina Smith · D-MN | Senate | Sold | $100,001 - $250,000 |
Not a model pick — but on our radar.
INSULET CORP isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
0
New positions
4
Increasing
1
Decreasing
2
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+248%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+28%
0.1% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+377%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+58%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.4×
% of portfolio
0.4%
Position change
—
0.4% of Baillie Gifford & Co's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−38%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
—
0.0% of Gotham Asset Mgmt's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to INSULET CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell INSULET CORP or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime